Cohort Profile: The Swiss Hepatitis C Cohort Study (SCCS)
Open Access
- 3 May 2007
- journal article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 36 (4), 731-737
- https://doi.org/10.1093/ije/dym096
Abstract
The hepatitis C virus, formerly classified as ‘non-A non-B’ hepatitis virus, was identified in 1989.1 This blood-borne virus is endemic worldwide, with an estimated 170 million persons chronically infected, representing approximately 3% of the world population.2 Long-term morbidity associated with persistent hepatitis C virus infection includes the development of cirrhosis and primary liver cancer.Keywords
This publication has 12 references indexed in Scilit:
- Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort studyThe Lancet, 2005
- Migrants from Sub-Saharan Africa in the Swiss HIV Cohort StudyAIDS, 2003
- The epidemiology of hepatitis C in a UK health regional population of 5.12 millionGut, 2001
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJAMA, 1999
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Prognosis of chronic hepatitis c: Results of a large, prospective cohort studyHepatology, 1998
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patientsHepatology, 1997
- The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristicsInternational Journal of Public Health, 1994
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989